3,823 results on '"Thrombotic Microangiopathies"'
Search Results
2. Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
3. Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma
4. The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
5. Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura: Multicentric Non-inferiority Single-arm Study (PEX-FREE)
6. Study of Ravulizumab in Pediatric Participants With HSCT-TMA
7. Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy
8. Therapeutic Orientation Test in Thrombotic Microangiopathy (TOTEM)
9. TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
10. Efficacy and safety of daratumumab in multiresistant immune‐mediated thrombotic thrombocytopenic purpura.
11. Immune‐mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report.
12. ADAMTS13 in the New Era of TTP.
13. Risk factors of death or chronic renal replacement therapy requirements in patients with thrombotic microangiopathies without ADAMTS‐13 deficiency.
14. Features and Relapse/Refractory Disease Risk Factors of Patients with Acquired Thrombotic Thrombocytopenic Purpura in the Western Mediterranean Region of Turkey.
15. Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger
16. Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy
17. Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA
18. Study of Patients With Thrombotic Microangiopathy Associated With Mitomycin C, Treated or Not With Eculizumab (m-TMA)
19. National Registry of Rare Kidney Diseases (RaDaR)
20. Urinary complement biomarkers in immune-mediated kidney diseases.
21. Nephrologische Notfälle.
22. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians.
23. Mortality risk associated with weekend and holiday hospitalizations amongst patients with hematological malignancies and febrile neutropenia.
24. Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation (PHASAL-GA)
25. Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
26. Automated Surveillance, Alert, and Rapid Diagnosis of Thrombotic Microangiopathies: the ASARD-TMA Study (ASARD-TMA)
27. French National Cohort MATRIX "Renal and Systemic Thrombotic Microangiopathy" (MATRIX)
28. Fulminant Recurrent Thrombosis in a Patient with Catastrophic Antiphospholipid Syndrome and Its Thirty-Day Outcome
29. Fulminant Recurrent Thrombosis in a Patient with Catastrophic Antiphospholipid Syndrome and Its Thirty-Day Outcome.
30. HELLP Syndrome and Differential Diagnosis with Other Thrombotic Microangiopathies in Pregnancy.
31. Immune-mediated thrombotic thrombocytopenic purpura: don't miss the boat.
32. Rational use of eculizumab in secondary atypical hemolytic uremic syndrome.
33. A Case Report on the Successful Management of Catastrophic Antiphospholipid Syndrome: Multidisciplinary Approach.
34. Atypical hemolytic uremic syndrome in a child: A rare case report.
35. Near-fatal cocaine intoxication in an infant with thrombotic microangiopathy associated with multiple organ failure.
36. Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus
37. Multicenter, Uncontrolled Pilot Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies (GEMECULI)
38. Ravulizumab and COVID-19
39. Cave canem! Diarrhö, Thrombozytopenie und „acute kidney injury" bei immunsupprimierter Patientin.
40. Construction of a Database for TMA
41. Clinical characteristics, treatments, and outcomes of interferon-beta-induced thrombotic microangiopathy: a literature-based retrospective analysis.
42. Clinical features of women with thrombotic microangiopathy in pregnancy: A case series from a single Japanese tertiary perinatal care center.
43. A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.
44. Plasma exchange for treatment of a therapy‐related thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma—A case report.
45. ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
46. Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?
47. Hereditary Thrombotic Thrombocytopenic Purpura.
48. Thrombotische Mikroangiopathien: Interdisziplinäre Zusammenarbeit gefragt!
49. Pregnancy as a susceptible state for thrombotic microangiopathies
50. Atypical hemolytic uremic syndrome in a child: A rare case report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.